Back to search
Women With BRCA1 Germline Deleterious Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Women With BRCA1 Germline Deleterious Mutation trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Women With BRCA1 Germline Deleterious Mutation trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
BRCA1 carriers who are at high risk of developing either a relapse and/or a new cancer growth will be included. These patients will be followed up during 30 mon…
A Phase 2, open-label, single-arm trial to evaluate the response of rucaparib in participants with various solid tumors and with deleterious mutations in Homolo…
Background: \- The new drug BMN 673 (talazoparib) has been shown to fight tumor cells in animals and some people. It is a poly (ADP-ribose) polymerase (PARP) i…